Anterior Uveitis Clinical Trial
Official title:
Intra-cameral Penetration of Ganciclovir Following Topical Administration of 0.15% Ganciclovir Gel (VIRGAN©) for CMV Anterior Uveitis / Endotheliitis
Objective of this study is to investigate the intracameral level of ganciclovir following topical application of 0.15% ganciclovir gel (VIRGAN©) for Cytomegalovirus (CMV) anterior uveitis and endothelitis. Thirty patients who are diagnosed with CMV anterior segment infection, either uveitis or endothelitis, who have a positive aqueous real time PCR (RT-PCR) and/or positive tetraplex PCR for CMV and have not had any form of ganciclovir treatment in the past 1 month, will be recruited in the study after taking an informed consent. with active CMV anterior segment infection confirmed by a positive aqueous real time PCR (RT-PCR) and have not had any form of ganciclovir treatment in the past 1 month were recruited in the study. Patients were given 0.15% ganciclovir gel 1cc 5 times a day for 6 weeks. Following 6 weeks of treatment, tears and aqueous samples will be collected. Aqueous will be sent for RT-PCR for CMV status. Ganciclovir drug level in both tears and aqueous will be measured by HPLC method. Clinically, degree of the intraocular inflammation, Intraocular pressure (IOP) and central corneal thickness (CCT) will be recorded at baseline and post-treatment.
n/a
Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00476593 -
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
|
N/A | |
Recruiting |
NCT01486693 -
Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis
|
N/A | |
Recruiting |
NCT01156285 -
Acute Anterior Uveitis: Psychic Burden and Pain
|
N/A | |
Terminated |
NCT00333996 -
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
|
Phase 2/Phase 3 | |
Completed |
NCT00405496 -
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
|
Phase 2 | |
Completed |
NCT02764697 -
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
|
Phase 4 | |
Completed |
NCT01376362 -
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
|
Phase 1/Phase 2 | |
Recruiting |
NCT00407316 -
Quality of Life and Visual Function in Uveitis Patients
|
Phase 0 | |
Completed |
NCT02725177 -
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
|
N/A | |
Completed |
NCT00823173 -
Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis
|
Phase 2 | |
Completed |
NCT02517619 -
Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis
|
Phase 3 | |
Completed |
NCT01505088 -
Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis
|
Phase 3 | |
Completed |
NCT02879084 -
Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
|
||
Completed |
NCT02765308 -
Aqueous Humor Dynamics and Hypertensive Uveitis
|
N/A | |
Completed |
NCT01154010 -
PEMF: an Adjunct Therapy for Anterior Uveitis
|
N/A | |
Completed |
NCT00130637 -
Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
|
Phase 2 | |
Completed |
NCT00406887 -
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
|
Phase 3 | |
Completed |
NCT00876434 -
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
|
Phase 1 |